Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Partnership to take recruitment and development of top-science executives to new level

Abstract:
In response to the growing war for top talent, a unique strategic alliance is announced today between NEXUSBioMed, a highly-specialized boutique executive search firm specializing in the physical and life sciences, and HUMANeX Ventures®, a leading talent-driven consulting, training, coaching, research, and assessment firm.

Partnership to take recruitment and development of top-science executives to new level

Irvine, CA | Posted on August 25th, 2009

The partnership aims to establish long-term, collaborative relationships with companies in the physical and life science industries and provide them with an innovative, integrated approach to talent search, acquisition, and development.

NEXUSBioMed is led by Adriana Petersen, a reputable executive recruiter with more than 25 years of experience and in excess of 3,000 successful placements around the world, and Michael Terlaak, a seasoned entrepreneur with a 20-year track record of successful ventures in a range of industries who leads the company's NEXUSNanoTec division. Brad Black founded HUMANeX Ventures® to combine more than 25 years of his own experience in the development of human capital and building cultures of excellence with the expertise of a team of seasoned "Practitioner Scientists" who have driven scientifically-grounded talent selection practices for organizations across the country.

The two organizations will join forces not only to identify the very best talent for executive-level roles in science-based companies across the country, but also provide clients with measurable data to support the talent identification and selection process through HUMANeX Ventures® scientifically-driven assessment tools. Furthermore, with the development, training, coaching and assessment practices offered by HUMANeX Ventures®, the partnership will provide clients with something that most, if not all other executive search firms cannot: support in the growth and development of human capital AFTER the placement is complete.

"The executive search and recruitment industry is saturated with firms that offer no services beyond recruitment. Similarly, there isn't another talent assessment and development resource that offers the expert-level search capabilities that we can provide through this partnership," said Petersen. "Together, we are unparalleled in our ability to offer top-notch recruitment services supported by scientifically-based assessment practices, not to mention the ongoing partnership with HUMANeX Ventures® to develop an organization's human capital and grow its overall culture."

Petersen added, "This partnership with HUMANeX Ventures® allows us to stand out among other larger firms because we can provide a level of service and expertise that rivals their own menu of services, but with a personal, specialized and more nimble approach that they simply cannot match."

NEXUSBioMed's leadership understands the present and future impact of companies throughout the physical and life sciences, so the partnership between HUMANeX Ventures® and NEXUSBioMed will serve the biomed, pharmaceutical, medical device, healthcare and medical industries. Additionally, in a special effort to support organizations in the rapidly growing nanotechnology industry, NEXUSBioMed has established NEXUSNanoTec. A division of NEXUSBioMed, NEXUSNanoTec specifically addresses the growing need for talent and leadership within the advanced science of nanotechnology. This specialized division partners with start-ups and emerging organizations, as well as those that seed and support them.

Led by NEXUSBioMed co-founder, Michael Terlaak, NEXUSNanoTec is heavily connected and networked within nanotechnology, including professionals in academia, leading scientists, highly-regarded researchers and experts in the private sector. The division will apply the talent acquisition and development processes offered the though NEXUSBioMed and HUMANeX Ventures partnership to support Angel and Seed Investors, venture capitalists, private equity firms, start-ups and emerging companies.

"It is our goal at NEXUSBioMed to build extraordinary teams of talented professionals and leadership that will ensure the success of companies in all the sciences," said Terlaak. "Additionally, through the creation of NEXUSNanoTec, we are extremely well-equipped to help companies involved in nanotechnology grow and help their technologies and products reach the market successfully. We are confident that the best first step in seeing that our clients succeed is by teaming with HUMANeX Ventures to provide objective, scientifically-sound, third-party tools and processes to finding the very best people to lead these growing companies."

The third party assessment process provided by HUMANeX is based on decades of scientific, evidence-based research. The tools and practices used in the selection process ensure the objective, accurate, secure, and measureable identification of specific talents for specific roles within client companies.

"Our assessment tools are founded on qualitative and quantitative data collection, scientific research, and expert analysis," said Black. "We provide the objective, measurable data to both simplify and solidify the executive recruitment process offered by HUMANeX Ventures®. The marriage of our two top models of how to select talent into an organization will bring success to many, many science-based organizations that commit to applying our practices."

HUMANeX Ventures® will also offer clients its integrated services in growing and developing the executive talent they select to join their teams, as well as tools and training to transform their organizations into talent-driven businesses with magnetic workplace cultures of excellence.

"The added value we bring to this partnership, beyond the evidence-based assessment instruments, is our ability to partner with these client organizations to help them take the top performers they select to join their teams and further develop them to reach each individual's potential," said Black. "We don't stop with recruitment of top talent; talent alone isn't enough. You have to develop it and build a culture that nurtures and supports it. You have to create teams of excellence and establish a culture that is committed to excellence and that will attract more top performers who want to be a part of what's happening in your organization. HUMANeX Ventures® has designed a process to help organizations do just that; we're excited to work with NEXUSBioMed to share that process with more leaders and organizations."

In announcing this partnership, NEXUSBioMed and HUMANeX Ventures® are committing to supporting organizations in creation and development of world-class teams that will drive their organizations to new and previously unattainable levels of excellence and success.

Michael Terlaak is the Founder of the Nanotechnology Research Foundation and Adriana Petersen is a Founding Board Member.

####

About NEXUSBioMed
To learn more about NEXUSBioMed, visit www.nexusbiomedresearch.com.

More information about HUMANeX Ventures® can be found on its website, www.humanexventures.com.

For more information, please click here

Contacts:
HUMANeX Ventures
Lindsay Tjepkema
773.459.0408

Copyright © NEXUSBioMed

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Jobs

Participate in the development of Malaysia’s National Graphene Action Plan 2020 October 10th, 2016

Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016

SUNY Poly Welcomes DPS as the Global Engineering Firm Opens Its U.S. Advanced Technology Group Headquarters at Cutting-Edge ZEN Building November 20th, 2015

SUNY Poly CNSE Announces Milestone as M+W Group Opens U.S. Headquarters at Albany Nanotech Complex and Research Alliance Begins $105M Solar Power Initiative October 20th, 2015

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Alliances/Trade associations/Partnerships/Distributorships

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Mechanism for sodium storage in 2-D material: Tin selenide is an effective host for storing sodium ions, making it a promising material for sodium ion batteries October 27th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project